Publications

Publications published since 2008 from OUS - Center for Clinical Heart Research

246 publications found

Publications 2020

  1. Arnesen H, Myhre PL, Seljeflot I (2020)
    Very Long Chain Marine n-3 Polyunsaturated Fatty Acids in Atherothrombotic Heart Disease. A Brief Review, with a Focus on Metabolic Effects
    Nutrients, 12 (10)
    DOI 10.3390/nu12103014, PubMed 33008057
  2. Bratseth V, Margeirsdottir HD, Chiva-Blanch G, Heier M, Solheim S, Arnesen H, Dahl-Jørgensen K, Seljeflot I (2020)
    Annexin V+ Microvesicles in Children and Adolescents with Type 1 Diabetes: A Prospective Cohort Study
    J Diabetes Res, 2020, 7216863
    DOI 10.1155/2020/7216863, PubMed 32309448
  3. Bratseth V, Margeirsdottir HD, Heier M, Solheim S, Arnesen H, Dahl-Jørgensen K, Seljeflot I (2020)
    Procoagulant activity in children and adolescents on intensive insulin therapy
    Pediatr Diabetes, 21 (3), 496-504
    DOI 10.1111/pedi.12978, PubMed 31943582
  4. Danielsen SO, Moons P, Leegaard M, Solheim S, Tønnessen T, Lie I (2020)
    Facilitators of and barriers to reducing thirty-day readmissions and improving patient-reported outcomes after surgical aortic valve replacement: a process evaluation of the AVRre trial
    BMC Health Serv Res, 20 (1), 256
    DOI 10.1186/s12913-020-05125-5, PubMed 32220252
  5. Gustavsen A, Njerve IU, Sitras V, Haugen G, Tollofsrud PA, Akkok CA (2020)
    A young woman with a transfusion-related pregnancy complication
    Tidsskr. Nor. Laegeforen., 140 (1), 58-61
  6. Hilde JM, Hisdal J, Skjørten I, Hansteen V, Melsom MN, Grøtta OJ, Småstuen MC, Seljeflot I, Arnesen H, Humerfelt S, Steine K (2020)
    Left ventricular dysfunction in COPD without pulmonary hypertension
    PLoS One, 15 (7), e0235075
    DOI 10.1371/journal.pone.0235075, PubMed 32673327
  7. Holte KB, Svanteson M, Hanssen KF, Sveen KA, Seljeflot I, Solheim S, Sell DR, Monnier VM, Berg TJ (2020)
    Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
    PLoS One, 15 (5), e0233174
    DOI 10.1371/journal.pone.0233174, PubMed 32401813
  8. Kluge KE, Langseth MS, Bratseth V, Pettersen AÅ, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2020)
    Circulating levels of the terminal complement complex are associated with hypercoagulability in patients with stable coronary artery disease
    Thromb Res, 196, 106-108 (in press)
    DOI 10.1016/j.thromres.2020.08.023, PubMed 32853976
  9. Kluge KE, Langseth MS, Opstad TB, Pettersen AÅ, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2020)
    Complement Activation in Association with Markers of Neutrophil Extracellular Traps and Acute Myocardial Infarction in Stable Coronary Artery Disease
    Mediators Inflamm, 2020, 5080743
    DOI 10.1155/2020/5080743, PubMed 32308555
  10. Kummen M, Solberg OG, Storm-Larsen C, Holm K, Ragnarsson A, Trøseid M, Vestad B, Skårdal R, Yndestad A, Ueland T, Svardal A, Berge RK, Seljeflot I, Gullestad L, Karlsen TH, Aaberge L, Aukrust P, Hov JR (2020)
    Rosuvastatin alters the genetic composition of the human gut microbiome
    Sci Rep, 10 (1), 5397
    DOI 10.1038/s41598-020-62261-y, PubMed 32214138
  11. Langseth MS, Helseth R, Ritschel V, Hansen CH, Andersen GØ, Eritsland J, Halvorsen S, Fagerland MW, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2020)
    Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
    Sci Rep, 10 (1), 5007
    DOI 10.1038/s41598-020-61971-7, PubMed 32193509
  12. Mayerhofer CCK, Kummen M, Holm K, Broch K, Awoyemi A, Vestad B, Storm-Larsen C, Seljeflot I, Ueland T, Bohov P, Berge RK, Svardal A, Gullestad L, Yndestad A, Aukrust P, Hov JR, Trøseid M (2020)
    Low fibre intake is associated with gut microbiota alterations in chronic heart failure
    ESC Heart Fail, 7 (2), 456-466
    DOI 10.1002/ehf2.12596, PubMed 31978943
  13. Mirza Y, Prestgaard EE, Selmer R, Liestol K, Grundvold I, Erikssen JE, Kjeldsen SE, Gjesdal K (2020)
    Ten-Year Prediction of cardiovascular disease in healthy Norwegian men based on NORRISK-2
    Tidsskr. Nor. Laegeforen., 140 (12), 1240-1246
  14. Mirza Y, Prestgaard EE, Selmer R, Liestøl K, Grundvold I, Erikssen JE, Kjeldsen SE, Gjesdal K (2020)
    Tiårsprediksjon av hjerte- og karsykdom hos friske norske menn basert på NORRISK-2
    Tidsskr Nor Laegeforen, 140 (12)
    DOI 10.4045/tidsskr.20.0089, PubMed 32900157
  15. Nakstad ER, Stær-Jensen H, Wimmer H, Henriksen J, Alteheld LH, Reichenbach A, Drægni T, Šaltytė-Benth J, Wilson JA, Etholm L, Øijordsbakken M, Eritsland J, Seljeflot I, Jacobsen D, Andersen GØ, Lundqvist C, Sunde K (2020)
    Late awakening, prognostic factors and long-term outcome in out-of-hospital cardiac arrest - results of the prospective Norwegian Cardio-Respiratory Arrest Study (NORCAST)
    Resuscitation, 149, 170-179
    DOI 10.1016/j.resuscitation.2019.12.031, PubMed 31926258
  16. Opstad TB, Kalstad AA, Holte KB, Berg TJ, Solheim S, Arnesen H, Seljeflot I (2020)
    Shorter Leukocyte Telomere Lengths in Healthy Relatives of Patients with Coronary Heart Disease
    Rejuvenation Res, 23 (4), 324-332
    DOI 10.1089/rej.2019.2258, PubMed 31805818
  17. Piuhola J, Kerkelä R, Laine M, Andersen GØ, Ērglis A, Kumsārs I, Thuesen L, Sinisalo J, Niemelä M, Junttila MJ (2020)
    Lower ST-elevation myocardial infarction incidence during COVID-19 epidemic in Northern Europe
    Scand Cardiovasc J
    DOI 10.1080/14017431.2020.1820563, PubMed 32945201
  18. Prestgaard E, Mariampillai J, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Kjeldsen S, Grundvold I, Berge E (2020)
    Change in Body Weight and Long-Term Risk of Stroke and Death in Healthy Men
    Stroke, 51 (5), 1435-1441
    DOI 10.1161/STROKEAHA.119.027233, PubMed 32268850
  19. Sandven I, Eritsland J, Abdelnoor M (2020)
    Remote Ischemic Conditioning in Patients with Acute Coronary Syndromes: A Systematic Review with Meta-Analysis and Trial Sequential Analysis
    Clin Epidemiol, 12, 595-605
    DOI 10.2147/CLEP.S249785, PubMed 32606985
  20. Trøseid M, Andersen GØ, Broch K, Hov JR (2020)
    The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
    EBioMedicine, 52, 102649
    DOI 10.1016/j.ebiom.2020.102649, PubMed 32062353
  21. Åkra S, Aksnes TA, Flaa A, Eggesbø HB, Opstad TB, Njerve IU, Seljeflot I (2020)
    Markers of remodeling in subcutaneous adipose tissue are strongly associated with overweight and insulin sensitivity in healthy non-obese men
    Sci Rep, 10 (1), 14055
    DOI 10.1038/s41598-020-71109-4, PubMed 32820223

Publications 2019

  1. Abdelnoor M, Sandven I, Vengen Ø, Risnes I (2019)
    Mediastinitis in open heart surgery: a systematic review and meta-analysis of risk factors
    Scand Cardiovasc J, 53 (5), 226-234
    DOI 10.1080/14017431.2019.1642508, PubMed 31290699
  2. Anstensrud AK, Woxholt S, Sharma K, Broch K, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damås JK, Hopp E, Kleveland O, Stensæth KH, Opdahl A, Kløw NE, Seljeflot I, Andersen GØ, Wiseth R, Aukrust P, Gullestad L (2019)
    Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
    Open Heart, 6 (2), e001108
    DOI 10.1136/openhrt-2019-001108, PubMed 31673391
  3. Atar D, Grundvold I (2019)
    On-label reduced doses of non-vitamin K anticoagulants prove safe and efficient; yet how to ensure the correct dose for the right patient?
    Eur Heart J, 40 (19), 1501-1503
    DOI 10.1093/eurheartj/ehz014, PubMed 30753396
  4. Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2019)
    Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population
    Atherosclerosis, 286, 53-59
    DOI 10.1016/j.atherosclerosis.2019.05.004, PubMed 31100620
  5. Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2019)
    Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
    Blood Press, 29 (2), 123-134
    DOI 10.1080/08037051.2019.1684817, PubMed 31718316
  6. Bratseth V, Chiva-Blanch G, Byrkjeland R, Solheim S, Arnesen H, Seljeflot I (2019)
    Elevated levels of circulating microvesicles in coronary artery disease patients with type 2 diabetes and albuminuria: Effects of exercise training
    Diab Vasc Dis Res, 16 (5), 431-439
    DOI 10.1177/1479164119843094, PubMed 31023084
  7. Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2019)
    High Adherence to the Nordic Diet Is Associated with Lower Levels of Total and Platelet-Derived Circulating Microvesicles in a Norwegian Population
    Nutrients, 11 (5)
    DOI 10.3390/nu11051114, PubMed 31109111
  8. Cwikiel J, Seljeflot I, Fagerland MW, Wachtell K, Arnesen H, Berge E, Flaa A (2019)
    High-sensitive cardiac Troponin T and exercise stress test for evaluation of angiographically significant coronary disease
    Int J Cardiol, 287, 1-6
    DOI 10.1016/j.ijcard.2019.04.019, PubMed 31006595
  9. Danielsen SO, Moons P, Sandvik L, Leegaard M, Solheim S, Tønnessen T, Lie I (2019)
    Impact of telephone follow-up and 24/7 hotline on 30-day readmission rates following aortic valve replacement -A randomized controlled trial
    Int J Cardiol, 300, 66-72
    DOI 10.1016/j.ijcard.2019.07.087, PubMed 31387822
  10. Ellingsen DG, Chashchin M, Seljeflot I, Berlinger B, Chashchin V, Stockfelt L, Thomassen Y (2019)
    A study of atherothrombotic biomarkers in welders
    Int Arch Occup Environ Health, 92 (7), 1023-1031
    DOI 10.1007/s00420-019-01441-4, PubMed 31114965
  11. Eritsland J, Andersen GO (2019)
    MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI (vol 13, e0206723, 2018)
    PLoS One, 14 (3), e0213636
  12. Helseth R, Knudsen EC, Eritsland J, Opstad TB, Arnesen H, Andersen GØ, Seljeflot I (2019)
    Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study
    BMC Cardiovasc Disord, 19 (1), 221
    DOI 10.1186/s12872-019-1205-1, PubMed 31615411
  13. Helseth R, Shetelig C, Andersen GØ, Langseth MS, Limalanathan S, Opstad TB, Arnesen H, Hoffmann P, Eritsland J, Seljeflot I (2019)
    Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
    Mediators Inflamm, 2019, 7816491
    DOI 10.1155/2019/7816491, PubMed 31772506
  14. Holte KB, Svanteson M, Hanssen KF, Haig Y, Solheim S, Berg TJ (2019)
    Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
    J Diabetes Complications, 33 (5), 383-389
    DOI 10.1016/j.jdiacomp.2019.01.006, PubMed 30846232
  15. Kalstad AA, Tveit S, Myhre PL, Laake K, Opstad TB, Tveit A, Schmidt EB, Solheim S, Arnesen H, Seljeflot I (2019)
    Leukocyte telomere length and serum polyunsaturated fatty acids, dietary habits, cardiovascular risk factors and features of myocardial infarction in elderly patients
    BMC Geriatr, 19 (1), 376
    DOI 10.1186/s12877-019-1383-9, PubMed 31881852
  16. Karlsen H, Bergan HA, Halvorsen PS, Sunde K, Qvigstad E, Andersen GØ, Bugge JF, Olasveengen TM (2019)
    Esmolol for cardioprotection during resuscitation with adrenaline in an ischaemic porcine cardiac arrest model
    Intensive Care Med Exp, 7 (1), 65
    DOI 10.1186/s40635-019-0279-5, PubMed 31802327
  17. Knudsen EC, Seljeflot I, Aksnes TA, Eritsland J, Arnesen H, Andersen GØ (2019)
    IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
    PLoS One, 14 (4), e0215640
    DOI 10.1371/journal.pone.0215640, PubMed 31002684
  18. Kvakkestad KM, Gran JM, Eritsland J, Holst Hansen C, Fossum E, Andersen GØ, Halvorsen S (2019)
    Long-Term Survival after Invasive or Conservative Strategy in Elderly Patients with non-ST-Elevation Myocardial Infarction: A Prospective Cohort Study
    Cardiology, 144 (3-4), 79-89
    DOI 10.1159/000503442, PubMed 31689705
  19. Lunde NN, Gregersen I, Ueland T, Shetelig C, Holm S, Kong XY, Michelsen AE, Otterdal K, Yndestad A, Broch K, Gullestad L, Nyman TA, Bendz B, Eritsland J, Hoffmann P, Skagen K, Gonçalves I, Nilsson J, Grenegård M, Poreba M, Drag M, Seljeflot I, Sporsheim B, Espevik T, Skjelland M et al. (2019)
    Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages
    Atherosclerosis, 296, 74-82
    DOI 10.1016/j.atherosclerosis.2019.12.008, PubMed 31870625
  20. Mariampillai JE, Liestøl K, Kjeldsen SE, Prestgaard EE, Engeseth K, Bodegard J, Berge E, Gjesdal K, Erikssen J, Grundvold I, Skretteberg PT (2019)
    Exercise Systolic Blood Pressure at Moderate Workload Is Linearly Associated With Coronary Disease Risk in Healthy Men
    Hypertension, 75 (1), 44-50
    DOI 10.1161/HYPERTENSIONAHA.119.13528, PubMed 31735088
  21. Mariampillai JE, Prestgaard EE, Kjeldsen SE, Liestøl K, Engeseth K, Erikssen J, Bodegard J, Berge E, Grundvold I, Skretteberg PT (2019)
    SBP above 180 mmHg at moderate exercise workload increases coronary heart disease risk in healthy men during 28-year follow-up
    J Hypertens, 37 (5), 949-955
    DOI 10.1097/HJH.0000000000001959, PubMed 30325341
  22. Mayerhofer CCK, Awoyemi A, Hov JR, Trøseid M, Broch K (2019)
    Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure
    ESC Heart Fail, 6 (3), 557-558
    DOI 10.1002/ehf2.12437, PubMed 31034162
  23. Opstad TB, Kalstad AA, Pettersen AÅ, Arnesen H, Seljeflot I (2019)
    Novel biomolecules of ageing, sex differences and potential underlying mechanisms of telomere shortening in coronary artery disease
    Exp Gerontol, 119, 53-60
    DOI 10.1016/j.exger.2019.01.020, PubMed 30684534
  24. Røe ÅT, Ruud M, Espe EK, Manfra O, Longobardi S, Aronsen JM, Nordén ES, Husebye T, Kolstad TRS, Cataliotti A, Christensen G, Sejersted OM, Niederer SA, Andersen GØ, Sjaastad I, Louch WE (2019)
    Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression
    Cardiovasc Res, 115 (4), 752-764
    DOI 10.1093/cvr/cvy257, PubMed 30351410
  25. Schultz NH, Holme PA, Henriksson CE, Mowinckel MC, Sandset PM, Bratseth V, Jacobsen EM (2019)
    The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis
    Thromb Res, 177, 154-156
    DOI 10.1016/j.thromres.2019.03.010, PubMed 30903875
  26. Solberg OG, Stavem K, Ragnarsson A, Beitnes JO, Skårdal R, Seljeflot I, Ueland T, Aukrust P, Gullestad L, Aaberge L (2019)
    Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study
    Catheter Cardiovasc Interv, 94 (5), 660-668
    DOI 10.1002/ccd.28157, PubMed 30790446
  27. Tveit SH, Myhre PL, Hoff NJS, Le TM, Seljeflot I, Røysland R, Høiseth AD, Røsjø H, Omland T (2019)
    Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; data from the Akershus cardiac Examination (ACE) 3 study
    Clin Biochem, 78, 10-17
    DOI 10.1016/j.clinbiochem.2019.12.016, PubMed 31899280
  28. Warlo EMK, Arnesen H, Seljeflot I (2019)
    A brief review on resistance to P2Y12 receptor antagonism in coronary artery disease
    Thromb J, 17, 11
    DOI 10.1186/s12959-019-0197-5, PubMed 31198410
  29. Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
    Effects of exercise training on inflammasome-related mediators and their associations to glucometabolic variables in patients with combined coronary artery disease and type 2 diabetes mellitus: Sub-study of a randomized control trial
    Diab Vasc Dis Res, 16 (4), 360-368
    DOI 10.1177/1479164119836922, PubMed 30939905
  30. Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
    Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial
    Diabetol Metab Syndr, 11, 109
    DOI 10.1186/s13098-019-0508-9, PubMed 31890043

Publications 2018

  1. Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2018)
    Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study
    Diabetol Metab Syndr, 10, 59
    DOI 10.1186/s13098-018-0360-3, PubMed 30038669
  2. Bethke A, Shanmuganathan L, Andersen GØ, Eritsland J, Swanson D, Kløw NE, Hoffmann P (2018)
    Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings
    Eur Radiol, 29 (2), 941-950
    DOI 10.1007/s00330-018-5588-7, PubMed 29980929
  3. Bethke A, Shanmuganathan L, Shetelig C, Swanson D, Andersen GØ, Eritsland J, Kløw NE, Hoffmann P (2018)
    MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
    PLoS One, 13 (11), e0206723
    DOI 10.1371/journal.pone.0206723, PubMed 30412607
  4. Cwikiel J, Seljeflot I, Berge E, Njerve IU, Ulsaker H, Arnesen H, Flaa A (2018)
    Effect of strenuous exercise on mediators of inflammation in patients with coronary artery disease
    Cytokine, 105, 17-22
    DOI 10.1016/j.cyto.2018.02.006, PubMed 29433015
  5. Danielsen SO, Moons P, Sandven I, Leegaard M, Solheim S, Tønnessen T, Lie I (2018)
    Thirty-day readmissions in surgical and transcatheter aortic valve replacement: A systematic review and meta-analysis
    Int J Cardiol, 268, 85-91
    DOI 10.1016/j.ijcard.2018.05.026, PubMed 29779575
  6. Dhillon AK, Kummen M, Trøseid M, Åkra S, Liaskou E, Moum B, Vesterhus M, Karlsen TH, Seljeflot I, Hov JR (2018)
    Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
    Liver Int, 39 (2), 371-381
    DOI 10.1111/liv.13979, PubMed 30269440
  7. Engeseth K, Prestgaard EE, Mariampillai JE, Grundvold I, Liestol K, Kjeldsen SE, Bodegard J, Erikssen JE, Gjesdal K, Skretteberg PT (2018)
    Physical fitness is a modifiable predictor of early cardiovascular death: A 35-year follow-up study of 2014 healthy middle-aged men
    Eur J Prev Cardiol, 25 (15), 1655-1663
    DOI 10.1177/2047487318793459, PubMed 30103630
  8. Hansen CH, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Seljeflot I (2018)
    Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
    Clin Appl Thromb Hemost, 24 (7), 1088-1094
    DOI 10.1177/1076029618764847, PubMed 29695176
  9. Heier M, Espeland CN, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Fugelseth D, Dahl-Jørgensen K (2018)
    Preserved endothelial function in young adults with type 1 diabetes
    PLoS One, 13 (10), e0206523
    DOI 10.1371/journal.pone.0206523, PubMed 30359432
  10. Heier M, Stensæth KH, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K (2018)
    Increased arterial stiffness in childhood onset diabetes: a cardiovascular magnetic resonance study
    Eur Heart J Cardiovasc Imaging, 19 (6), 694-700
    DOI 10.1093/ehjci/jex178, PubMed 28950341
  11. Hiis HG, Cosson MV, Dahl CP, Fiane AE, Levy FO, Andersen GØ, Krobert KA (2018)
    Hypothermia elongates the contraction-relaxation cycle in explanted human failing heart decreasing the time for ventricular filling during diastole
    Am J Physiol Heart Circ Physiol, 315 (5), H1137-H1147
    DOI 10.1152/ajpheart.00208.2018, PubMed 30004809
  12. Hoel H, Hove-Skovsgaard M, Hov JR, Gaardbo JC, Holm K, Kummen M, Rudi K, Nwosu F, Valeur J, Gelpi M, Seljeflot I, Ueland PM, Gerstoft J, Ullum H, Aukrust P, Nielsen SD, Trøseid M (2018)
    Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction
    Sci Rep, 8 (1), 6725
    DOI 10.1038/s41598-018-25168-3, PubMed 29712976
  13. Horjen AW, Ulimoen SR, Norseth J, Svendsen JH, Smith P, Arnesen H, Seljeflot I, Tveit A (2018)
    High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis
    Scand J Clin Lab Invest, 78 (5), 386-392
    DOI 10.1080/00365513.2018.1481224, PubMed 29933716
  14. Langseth MS, Opstad TB, Bratseth V, Solheim S, Arnesen H, Pettersen AÅ, Seljeflot I, Helseth R (2018)
    Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease
    Eur J Prev Cardiol, 25 (7), 762-769
    DOI 10.1177/2047487318760618, PubMed 29473463
  15. Mayerhofer CCK, Awoyemi AO, Moscavitch SD, Lappegård KT, Hov JR, Aukrust P, Hovland A, Lorenzo A, Halvorsen S, Seljeflot I, Gullestad L, Trøseid M, Broch K (2018)
    Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
    ESC Heart Fail, 5 (5), 977-984
    DOI 10.1002/ehf2.12332, PubMed 30088346
  16. Munkhaugen J, Hjelmesæth J, Otterstad JE, Helseth R, Sollid ST, Gjertsen E, Gullestad L, Perk J, Moum T, Husebye E, Dammen T (2018)
    Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study
    BMC Cardiovasc Disord, 18 (1), 160
    DOI 10.1186/s12872-018-0896-z, PubMed 30075751
  17. Orrem HL, Nilsson PH, Pischke SE, Grindheim G, Garred P, Seljeflot I, Husebye T, Aukrust P, Yndestad A, Andersen GØ, Barratt-Due A, Mollnes TE (2018)
    Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
    ESC Heart Fail, 5 (3), 292-301
    DOI 10.1002/ehf2.12266, PubMed 29424484
  18. Orrem HL, Nilsson PH, Pischke SE, Kleveland O, Yndestad A, Ekholt K, Damås JK, Espevik T, Bendz B, Halvorsen B, Gregersen I, Wiseth R, Andersen GØ, Ueland T, Gullestad L, Aukrust P, Barratt-Due A, Mollnes TE (2018)
    IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
    Front Immunol, 9, 2035
    DOI 10.3389/fimmu.2018.02035, PubMed 30258440
  19. Orrem HL, Shetelig C, Ueland T, Limalanathan S, Nilsson PH, Husebye T, Aukrust P, Seljeflot I, Hoffmann P, Eritsland J, Mollnes TE, Andersen GØ, Yndestad A (2018)
    Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
    Int J Cardiol, 268, 187-192
    DOI 10.1016/j.ijcard.2018.05.032, PubMed 29853279
  20. Prestgaard E, Mariampillai J, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Gjesdal K, Kjeldsen S, Grundvold I, Berge E (2018)
    Change in Cardiorespiratory Fitness and Risk of Stroke and Death
    Stroke, 50 (1), 155-161
    DOI 10.1161/STROKEAHA.118.021798, PubMed 30580727
  21. Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, Patrono C, Rubboli A, Seljeflot I, Sibbing D, Siegbahn A, Ten Berg J, Vilahur G, Verheugt FWA, Wallentin L, Weiss TW, Wojta J, Storey RF (2018)
    Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
    Eur Heart J, 39 (19), 1672-1686f
    DOI 10.1093/eurheartj/ehy066, PubMed 29509886
  22. Saetre E, Abdelnoor M (2018)
    Incidence rate of sudden death in epilepsy: A systematic review and meta-analysis
    Epilepsy Behav, 86, 193-199
    DOI 10.1016/j.yebeh.2018.06.037, PubMed 30017838
  23. Shetelig C, Limalanathan S, Hoffmann P, Seljeflot I, Gran JM, Eritsland J, Andersen GØ (2018)
    Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
    J Am Coll Cardiol, 72 (2), 187-198
    DOI 10.1016/j.jacc.2018.04.053, PubMed 29976293
  24. Staer-Jensen H, Sunde K, Nakstad ER, Eritsland J, Andersen GØ (2018)
    Comparison of three haemodynamic monitoring methods in comatose post cardiac arrest patients
    Scand Cardiovasc J, 52 (3), 141-148
    DOI 10.1080/14017431.2018.1450992, PubMed 29544369
  25. Åkra S, Aksnes TA, Flaa A, Eggesbø HB, Opstad TB, Njerve IU, Seljeflot I (2018)
    Interleukin-18 and the NLR family pyrin domain containing-3 inflammasome in adipose tissue are strongly associated with glucometabolic variables in a cohort of middle-aged men
    Diab Vasc Dis Res, 15 (5), 458-464
    DOI 10.1177/1479164118785307, PubMed 29972041

Publications 2017

  1. Abdelnoor M, Andersen JG, Arnesen H, Johansen O (2017)
    Early discharge compared with ordinary discharge after percutaneous coronary intervention - a systematic review and meta-analysis of safety and cost
    Vasc Health Risk Manag, 13, 101-109
    DOI 10.2147/VHRM.S122951, PubMed 28356750
  2. Bratseth V, Byrkjeland R, Njerve IU, Solheim S, Arnesen H, Seljeflot I (2017)
    Procoagulant activity in patients with combined type 2 diabetes and coronary artery disease: No effects of long-term exercise training
    Diab Vasc Dis Res, 14 (2), 144-151
    DOI 10.1177/1479164116679080, PubMed 28111966
  3. Byrkjeland R, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2017)
    Reduced endothelial activation after exercise is associated with improved HbA1c in patients with type 2 diabetes and coronary artery disease
    Diab Vasc Dis Res, 14 (2), 94-103
    DOI 10.1177/1479164116679077, PubMed 28111980
  4. Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2017)
    Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity
    PLoS One, 12 (2), e0172558
    DOI 10.1371/journal.pone.0172558, PubMed 28207887
  5. Cwikiel J, Seljeflot I, Berge E, Arnesen H, Wachtell K, Ulsaker H, Flaa A (2017)
    Pro-coagulant activity during exercise testing in patients with coronary artery disease
    Thromb J, 15, 3
    DOI 10.1186/s12959-016-0127-8, PubMed 28115916
  6. Ellingsen DG, Seljeflot I, Thomassen Y, Thomassen M, Bakke B, Ulvestad B (2017)
    Biomarkers of endothelial activation and thrombosis in tunnel construction workers exposed to airborne contaminants
    Int Arch Occup Environ Health, 90 (4), 309-317
    DOI 10.1007/s00420-017-1199-x, PubMed 28124139
  7. Gharagozlian S, Hansen R, Haugen M, Johansen O, Seierstad SL, Seljeflot I, Arnesen H (2017)
    Changes in dietary pattern when including 700 g of salmon per week to patients with atherosclerotic heart disease
    Clin. Nutr. ESPEN, 19, 38-44
  8. Heier M, Borja MS, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K, Oda MN (2017)
    Reduced HDL function in children and young adults with type 1 diabetes
    Cardiovasc Diabetol, 16 (1), 85
    DOI 10.1186/s12933-017-0570-2, PubMed 28683835
  9. Horjen AW, Seljeflot I, Berge T, Smith P, Arnesen H, Tveit A (2017)
    Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation
    Thromb J, 15, 30
    DOI 10.1186/s12959-017-0153-1, PubMed 29299030
  10. Hove-Skovsgaard M, Gaardbo JC, Kolte L, Winding K, Seljeflot I, Svardal A, Berge RK, Gerstoft J, Ullum H, Trøseid M, Nielsen SD (2017)
    HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation
    BMC Infect Dis, 17 (1), 234
    DOI 10.1186/s12879-017-2334-8, PubMed 28356058
  11. Husebye T, Eritsland J, Bjørnerheim R, Andersen GØ (2017)
    Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure
    Eur Heart J Acute Cardiovasc Care, 7 (4), 321-329
    DOI 10.1177/2048872616687114, PubMed 28045338
  12. Kvakkestad KM, Sandvik L, Andersen GØ, Sunde K, Halvorsen S (2017)
    Long-term survival in patients with acute myocardial infarction and out-of-hospital cardiac arrest: A prospective cohort study
    Resuscitation, 122, 41-47
    DOI 10.1016/j.resuscitation.2017.11.047, PubMed 29155294
  13. Lie I, Danielsen SO, Tønnessen T, Solheim S, Leegaard M, Sandvik L, Wisløff T, Vangen J, Røsstad TH, Moons P (2017)
    Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): study protocol for a randomised controlled trial
    Trials, 18 (1), 246
    DOI 10.1186/s13063-017-1971-y, PubMed 28693599
  14. Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Norseth J, Arnesen H, Solheim S (2017)
    Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study
    JRSM Cardiovasc Dis, 6, 2048004017729984
    DOI 10.1177/2048004017729984, PubMed 28932392
  15. Mariampillai JE, Engeseth K, Kjeldsen SE, Grundvold I, Liestøl K, Erikssen G, Erikssen J, Bodegard J, Skretteberg PT (2017)
    Exercise systolic blood pressure at moderate workload predicts cardiovascular disease and mortality through 35 years of follow-up in healthy, middle-aged men
    Blood Press, 26 (4), 229-236
    DOI 10.1080/08037051.2017.1291276, PubMed 28276720
  16. Myhre PL, Stridsberg M, Linko R, Okkonen M, Nygård S, Christensen G, Pettilä V, Omland T, Røsjø H, FINNALI Study Group (2017)
    Circulating chromogranin B levels in patients with acute respiratory failure: data from the FINNALI Study
    Biomarkers, 22 (8), 775-781
    DOI 10.1080/1354750X.2016.1269200, PubMed 28049363
  17. Njerve IU, Åkra S, Weiss TW, Solheim S, Øvstebø R, Aass HCD, Byrkjeland R, Arnesen H, Seljeflot I (2017)
    A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease
    Mediators Inflamm, 2017, 5380638
    DOI 10.1155/2017/5380638, PubMed 28596642
  18. Opstad TB, Seljeflot I, Bøhmer E, Arnesen H, Halvorsen S (2017)
    MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy
    Cardiology, 139 (1), 17-24
    DOI 10.1159/000481684, PubMed 29141241
  19. Prestgaard E, Hodnesdal C, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Gjesdal K, Kjeldsen SE, Grundvold I, Berge E (2017)
    Long-term predictors of stroke in healthy middle-aged men
    Int J Stroke, 13 (3), 292-300
    DOI 10.1177/1747493017730760, PubMed 28929941
  20. Ritschel V, Shetelig C, Seljeflot I, Limalanathan S, Hoffmann P, Halvorsen S, Arnesen H, Eritsland J, Andersen GØ (2017)
    Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
    Sci Rep, 7 (1), 11945
    DOI 10.1038/s41598-017-12372-w, PubMed 28931920
  21. Shetelig C, Limalanathan S, Eritsland J, Hoffmann P, Seljeflot I, Gran JM, Aukrust P, Ueland T, Andersen GØ (2017)
    Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
    PLoS One, 12 (3), e0173034
    DOI 10.1371/journal.pone.0173034, PubMed 28253327
  22. Warlo EMK, Pettersen AR, Arnesen H, Seljeflot I (2017)
    vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
    Thromb J, 15, 28
    DOI 10.1186/s12959-017-0151-3, PubMed 29200971
  23. Wexels F, Dahl OE, Pripp AH, Seljeflot I (2017)
    Thrombin Generation in Patients With Suspected Venous Thromboembolism
    Clin Appl Thromb Hemost, 23 (5), 416-421
    DOI 10.1177/1076029617700999, PubMed 28335612

Publications 2016

  1. Abdelnoor M, Vengen ØA, Johansen O, Sandven I, Abdelnoor AM (2016)
    Latitude of the study place and age of the patient are associated with incidence of mediastinitis and microbiology in open-heart surgery: a systematic review and meta-analysis
    Clin Epidemiol, 8, 151-63
    DOI 10.2147/CLEP.S96107, PubMed 27330329
  2. Beitland S, Nakstad ER, Staer-Jensen H, Draegni T, Andersen GØ, Jacobsen D, Brunborg C, Waldum-Grevbo B, Sunde K (2016)
    Impact of acute kidney injury on patient outcome in out-of-hospital cardiac arrest: a prospective observational study
    Acta Anaesthesiol Scand, 60 (8), 1170-81
    DOI 10.1111/aas.12753, PubMed 27306254
  3. Beitland S, Waldum-Grevbo BE, Nakstad ER, Berg JP, Trøseid AS, Brusletto BS, Brunborg C, Andersen GØ, Sunde K (2016)
    Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest
    Crit Care, 20 (1), 314
    DOI 10.1186/s13054-016-1503-2, PubMed 27716377
  4. Bliksøen M, Mariero LH, Torp MK, Baysa A, Ytrehus K, Haugen F, Seljeflot I, Vaage J, Valen G, Stensløkken KO (2016)
    Extracellular mtDNA activates NF-κB via toll-like receptor 9 and induces cell death in cardiomyocytes
    Basic Res Cardiol, 111 (4), 42
    DOI 10.1007/s00395-016-0553-6, PubMed 27164906
  5. Byrkjeland R, Stensæth KH, Anderssen S, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2016)
    Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques
    Cardiovasc Diabetol, 15, 13
    DOI 10.1186/s12933-016-0336-2, PubMed 26801098
  6. Chiva-Blanch G, Bratseth V, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Badimon L, Seljeflot I (2016)
    Monocyte-derived circulating microparticles (CD14+, CD14+/CD11b+ and CD14+/CD142+) are related to long-term prognosis for cardiovascular mortality in STEMI patients
    Int J Cardiol, 227, 876-881
    DOI 10.1016/j.ijcard.2016.11.302, PubMed 27915085
  7. Engeseth K, Hodnesdal C, Grundvold I, Liestøl K, Gjesdal K, Kjeldsen SE, Erikssen JE, Bodegard J, Skretteberg PT (2016)
    Temporal Reduction in Chronotropic Index Predicts Risk of Cardiovascular Death Among Healthy Middle-Aged Men: a 28-Year Follow-Up Study
    J Am Heart Assoc, 5 (12)
    DOI 10.1161/JAHA.116.004555, PubMed 27881424
  8. Haissman JM, Haugaard AK, Knudsen A, Kristoffersen US, Seljeflot I, Pedersen KK, Lebech AM, Hasbak P, Kjær A, Ostrowski SR, Gerstoft J, Trøseid M, Nielsen SD (2016)
    Marker of Endothelial Dysfunction Asymmetric Dimethylarginine Is Elevated in HIV Infection but Not Associated With Subclinical Atherosclerosis
    J Acquir Immune Defic Syndr, 73 (5), 507-513
    DOI 10.1097/QAI.0000000000001148, PubMed 27509250
  9. Helseth R, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2016)
    The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris
    Mediators Inflamm, 2016, 2182358
    DOI 10.1155/2016/2182358, PubMed 28074081
  10. Horjen AW, Ulimoen SR, Enger S, Norseth J, Seljeflot I, Arnesen H, Tveit A (2016)
    Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing
    BMC Cardiovasc Disord, 16, 79
    DOI 10.1186/s12872-016-0255-x, PubMed 27142292
  11. Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Arnesen H, Solheim S (2016)
    Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction
    J Lipids, 2016, 4945720
    DOI 10.1155/2016/4945720, PubMed 26989512
  12. Myhre PL, Ottesen AH, Okkonen M, Linko R, Stridsberg M, Nygård S, Christensen G, Pettilä V, Omland T, Røsjø H, FINNALI Laboratory Study Group (2016)
    Prognostic Value of Secretoneurin in Patients with Acute Respiratory Failure: Data from the FINNALI Study
    Clin Chem, 62 (10), 1380-9
    DOI 10.1373/clinchem.2016.258764, PubMed 27540029
  13. Myhre PL, Tiainen M, Pettilä V, Vaahersalo J, Hagve TA, Kurola J, Varpula T, Omland T, Røsjø H, FINNRESUSCI Laboratory Study Group (2016)
    NT-proBNP in patients with out-of-hospital cardiac arrest: Results from the FINNRESUSCI Study
    Resuscitation, 104, 12-8
    DOI 10.1016/j.resuscitation.2016.04.007, PubMed 27109503
  14. Neerland BE, Hall RJ, Seljeflot I, Frihagen F, MacLullich AM, Raeder J, Wyller TB, Watne LO (2016)
    Associations Between Delirium and Preoperative Cerebrospinal Fluid C-Reactive Protein, Interleukin-6, and Interleukin-6 Receptor in Individuals with Acute Hip Fracture
    J Am Geriatr Soc, 64 (7), 1456-63
    DOI 10.1111/jgs.14238, PubMed 27341529
  15. Njerve IU, Byrkjeland R, Arnesen H, Åkra S, Solheim S, Seljeflot I (2016)
    Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial
    Diabetes Metab Syndr Obes, 9, 55-62
    DOI 10.2147/DMSO.S96299, PubMed 27042130
  16. Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I (2016)
    Combined Elevated Levels of the Proinflammatory Cytokines IL-18 and IL-12 Are Associated with Clinical Events in Patients with Coronary Artery Disease: An Observational Study
    Metab Syndr Relat Disord, 14 (5), 242-8
    DOI 10.1089/met.2015.0130, PubMed 27058587
  17. Opstad TB, Brusletto BS, Arnesen H, Pettersen AÅ, Seljeflot I (2016)
    Cigarette smoking represses expression of cytokine IL-12 and its regulator miR-21-An observational study in patients with coronary artery disease
    Immunobiology, 222 (2), 169-175
    DOI 10.1016/j.imbio.2016.10.007, PubMed 27765464
  18. Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Eritsland J, Fagerland MW, Andersen GØ (2016)
    Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
    J Am Heart Assoc, 5 (6)
    DOI 10.1161/JAHA.115.003014, PubMed 27412895
  19. Santos-Gallego CG, Vahl TP, Goliasch G, Picatoste B, Arias T, Ishikawa K, Njerve IU, Sanz J, Narula J, Sengupta PP, Hajjar RJ, Fuster V, Badimon JJ (2016)
    Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion
    Circulation, 133 (10), 954-66
    DOI 10.1161/CIRCULATIONAHA.115.012427, PubMed 26826180
  20. Tegn N, Abdelnoor M, Aaberge L, Endresen K, Bendz B (2016)
    Invasive strategy in acute coronary syndrome - Authors' reply
    Lancet, 387 (10037), 2504
    DOI 10.1016/S0140-6736(16)30673-0, PubMed 27353680
  21. Tegn N, Abdelnoor M, Aaberge L, Endresen K, Smith P, Aakhus S, Gjertsen E, Dahl-Hofseth O, Ranhoff AH, Gullestad L, Bendz B, After Eighty study investigators (2016)
    Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial
    Lancet, 387 (10023), 1057-1065
    DOI 10.1016/S0140-6736(15)01166-6, PubMed 26794722
  22. Wexels F, Seljeflot I, Pripp AH, Dahl OE (2016)
    D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism
    Blood Coagul Fibrinolysis, 27 (4), 396-400
    DOI 10.1097/MBC.0000000000000461, PubMed 26595215

Publications 2015

  1. Andric T, Weiss TW, Huber K, Arnesen H, Seljeflot I (2015)
    Effects of diet and/or n-3 fatty acid supplementation on components of the interleukin-6 trans-signalling system in elderly men
    Scand J Clin Lab Invest, 75 (8), 646-51
    DOI 10.3109/00365513.2015.1063002, PubMed 26179891
  2. Berg IJ, van der Heijde D, Dagfinrud H, Seljeflot I, Olsen IC, Kvien TK, Semb AG, Provan SA (2015)
    Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study
    J Rheumatol, 42 (4), 645-53
    DOI 10.3899/jrheum.141018, PubMed 25641897
  3. Byrkjeland R, Njerve IU, Anderssen S, Arnesen H, Seljeflot I, Solheim S (2015)
    Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease: A randomised clinical trial
    Diab Vasc Dis Res, 12 (5), 325-33
    DOI 10.1177/1479164115590552, PubMed 26092822
  4. Ellingsen DG, Ulvestad B, Bakke B, Seljeflot I, Barregard L, Thomassen Y (2015)
    Serum pneumoproteins in tunnel construction workers
    Int Arch Occup Environ Health, 88 (7), 943-51
    DOI 10.1007/s00420-015-1023-4, PubMed 25632885
  5. Gjesdal K, Grundvold I (2015)
    Atrial fibrillation and exercise in women: some answers given, some questions remain
    Heart, 101 (20), 1605-6
    DOI 10.1136/heartjnl-2015-307836, PubMed 26206848
  6. Grundvold I, Bodegard J, Nilsson PM, Svennblad B, Johansson G, Östgren CJ, Sundström J (2015)
    Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study
    Cardiovasc Diabetol, 14, 5
    DOI 10.1186/s12933-014-0170-3, PubMed 25589001
  7. Halvorsen B, Espeland MZ, Andersen GØ, Yndestad A, Sagen EL, Rashidi A, Knudsen EC, Skjelland M, Skagen KR, Krohg-Sørensen K, Holm S, Ritschel V, Holven KB, Biessen EA, Aukrust P, Dahl TB (2015)
    Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages
    Atherosclerosis, 243 (1), 204-10
    DOI 10.1016/j.atherosclerosis.2015.09.010, PubMed 26402139
  8. Hansen CH, Ritschel V, Halvorsen S, Andersen GØ, Bjørnerheim R, Eritsland J, Arnesen H, Seljeflot I (2015)
    Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
    Thromb J, 13, 31
    DOI 10.1186/s12959-015-0061-1, PubMed 26396552
  9. Heier M, Margeirsdottir HD, Gaarder M, Stensæth KH, Brunborg C, Torjesen PA, Seljeflot I, Hanssen KF, Dahl-Jørgensen K (2015)
    Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
    Cardiovasc Diabetol, 14, 126
    DOI 10.1186/s12933-015-0292-2, PubMed 26408307
  10. Heier M, Margeirsdottir HD, Torjesen PA, Seljeflot I, Stensæth KH, Gaarder M, Brunborg C, Hanssen KF, Dahl-Jørgensen K (2015)
    The advanced glycation end product methylglyoxal-derived hydroimidazolone-1 and early signs of atherosclerosis in childhood diabetes
    Diab Vasc Dis Res, 12 (2), 139-45
    DOI 10.1177/1479164114560910, PubMed 25616705
  11. Helseth R, Opstad T, Solheim S, Lunde K, Arnesen H, Seljeflot I (2015)
    The Effect of Intracoronary Stem Cell Injection on Markers of Leukocyte Activation in Acute Myocardial Infarction
    Cardiol Res, 6 (1), 209-215
    DOI 10.14740/cr375w, PubMed 28197227
  12. Helseth R, Weiss TW, Opstad TB, Siegbahn A, Solheim S, Freynhofer MK, Huber K, Arnesen H, Seljeflot S (2015)
    Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction
    Thromb Res, 136 (6), 1240-4
    DOI 10.1016/j.thromres.2015.10.005, PubMed 26475405
  13. Horjen AW, Ulimoen SR, Seljeflot I, Smith P, Arnesen H, Norseth J, Tveit A (2015)
    High-Sensitivity Troponin I and Rhythm Outcome after Electrical Cardioversion for Persistent Atrial Fibrillation
    Cardiology, 133 (4), 233-8
    DOI 10.1159/000442249, PubMed 26697854
  14. Lindholm EE, Aune E, Seljeflot I, Otterstad JE, Kirkebøen KA (2015)
    Biomarkers of inflammation in major vascular surgery: a prospective randomised trial
    Acta Anaesthesiol Scand, 59 (6), 773-87
    DOI 10.1111/aas.12466, PubMed 25626738
  15. Laake K, Seljeflot I, Fagerland MW, Njerve IU, Arnesen H, Solheim S (2015)
    Effects on serum fractalkine by diet and omega-3 fatty acid intervention: relation to clinical outcome
    Mediators Inflamm, 2015, 373070
    DOI 10.1155/2015/373070, PubMed 25733777
  16. Pettersen AA, Arnesen H, Seljeflot I (2015)
    A brief review on high on-aspirin residual platelet reactivity
    Vascul Pharmacol, 67-69, 6-9
    DOI 10.1016/j.vph.2015.03.018, PubMed 25869498
  17. Skrede K, Wyller TB, Watne LO, Seljeflot I, Juliebø V (2015)
    Is there a role for monocyte chemoattractant protein-1 in delirium? Novel observations in elderly hip fracture patients
    BMC Res Notes, 8, 186
    DOI 10.1186/s13104-015-1129-5, PubMed 25943983
  18. Stær-Jensen H, Nakstad ER, Fossum E, Mangschau A, Eritsland J, Drægni T, Jacobsen D, Sunde K, Andersen GØ (2015)
    Post-Resuscitation ECG for Selection of Patients for Immediate Coronary Angiography in Out-of-Hospital Cardiac Arrest
    Circ Cardiovasc Interv, 8 (10)
    DOI 10.1161/CIRCINTERVENTIONS.115.002784, PubMed 26453688
  19. Sunde K, Andersen GØ (2015)
    Prediction of outcome after out-of-hospital cardiac arrest already on hospital admission-not reliable enough to be true!
    Eur Heart J, 37 (42), 3229-3231
    DOI 10.1093/eurheartj/ehv490, PubMed 26516178
  20. Trøseid M, Nestvold TK, Nielsen EW, Thoresen H, Seljeflot I, Lappegård KT (2015)
    Soluble CD14 is associated with markers of vascular dysfunction in bariatric surgery patients
    Metab Syndr Relat Disord, 13 (3), 119-24
    DOI 10.1089/met.2014.0111, PubMed 25562385
  21. Ørstavik Ø, Manfra O, Andressen KW, Andersen GØ, Skomedal T, Osnes JB, Levy FO, Krobert KA (2015)
    The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium
    PLoS One, 10 (3), e0115547
    DOI 10.1371/journal.pone.0115547, PubMed 25738589

Publications 2014

  1. Abdelnoor M, Sandven I, Limalanathan S, Eritsland J (2014)
    Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials
    Vasc Health Risk Manag, 10, 477-91
    DOI 10.2147/VHRM.S67154, PubMed 25143742
  2. Andersen GØ (2014)
    Circulatory shock
    N Engl J Med, 370 (6), 583
    DOI 10.1056/NEJMc1314999, PubMed 24499234
  3. Byrkjeland R, Edvardsen E, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2014)
    Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease
    Diabetol Metab Syndr, 6 (1), 36
    DOI 10.1186/1758-5996-6-36, PubMed 24612649
  4. Bøhmer E, Kristiansen IS, Arnesen H, Halvorsen S (2014)
    Health-related quality of life after myocardial infarction, does choice of method make a difference?
    Scand Cardiovasc J, 48 (4), 216-22
    DOI 10.3109/14017431.2014.923581, PubMed 24828790
  5. Engeseth K, Hodnesdal C, Grundvold I, Liestøl K, Gjesdal K, Erikssen G, Kjeldsen SE, Erikssen JE, Bodegard J, Skretteberg PT (2014)
    Heart rate reserve predicts cardiovascular death among physically unfit but otherwise healthy middle-aged men: a 35-year follow-up study
    Eur J Prev Cardiol, 23 (1), 59-66
    DOI 10.1177/2047487314553202, PubMed 25281482
  6. Furenes EB, Opstad TB, Solheim S, Lunde K, Arnesen H, Seljeflot I (2014)
    The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction
    Mediators Inflamm, 2014, 385901
    DOI 10.1155/2014/385901, PubMed 25294955
  7. Heier M, Margeirsdottir HD, Brunborg C, Hanssen KF, Dahl-Jørgensen K, Seljeflot I (2014)
    Inflammation in childhood type 1 diabetes; influence of glycemic control
    Atherosclerosis, 238 (1), 33-7
    DOI 10.1016/j.atherosclerosis.2014.11.018, PubMed 25437887
  8. Helseth R, Seljeflot I, Opstad T, Solheim S, Freynhofer M, Arnesen H, Huber K, Weiss T (2014)
    Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction
    Thromb Res, 135 (2), 329-33
    DOI 10.1016/j.thromres.2014.11.028, PubMed 25496999
  9. Helseth R, Solheim S, Opstad T, Hoffmann P, Arnesen H, Seljeflot I (2014)
    The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention
    Mediators Inflamm, 2014, 608414
    DOI 10.1155/2014/608414, PubMed 24737925
  10. Husebye T, Eritsland J, Arnesen H, Bjørnerheim R, Mangschau A, Seljeflot I, Andersen GØ (2014)
    Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure
    PLoS One, 9 (11), e112359
    DOI 10.1371/journal.pone.0112359, PubMed 25390695
  11. Husted S, de Caterina R, Andreotti F, Arnesen H, Bachmann F, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Storey RF, Weitz JI, ESC Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease (2014)
    Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel
    Thromb Haemost, 111 (5), 781-2
    DOI 10.1160/TH14-03-0228, PubMed 24658395
  12. Laake K, Myhre P, Nordby LM, Seljeflot I, Abdelnoor M, Smith P, Tveit A, Arnesen H, Solheim S (2014)
    Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study
    BMC Geriatr, 14, 74
    DOI 10.1186/1471-2318-14-74, PubMed 24928284
  13. Njerve IU, Solheim S, Lunde K, Hoffmann P, Arnesen H, Seljeflot I (2014)
    Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection
    Cytokine, 69 (1), 131-5
    DOI 10.1016/j.cyto.2014.05.022, PubMed 24930044
  14. Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I (2014)
    The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease
    PLoS One, 9 (9), e106816
    DOI 10.1371/journal.pone.0106816, PubMed 25191702
  15. Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Trøseid M (2014)
    Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
    J Acquir Immune Defic Syndr, 67 (4), 370-4
    DOI 10.1097/QAI.0000000000000339, PubMed 25226210
  16. Stær-Jensen H, Sunde K, Olasveengen TM, Jacobsen D, Drægni T, Nakstad ER, Eritsland J, Andersen GØ (2014)
    Bradycardia during therapeutic hypothermia is associated with good neurologic outcome in comatose survivors of out-of-hospital cardiac arrest
    Crit Care Med, 42 (11), 2401-8
    DOI 10.1097/CCM.0000000000000515, PubMed 25072762
  17. Sveen KA, Dahl-Jørgensen K, Stensaeth KH, Angel K, Seljeflot I, Sell DR, Monnier VM, Hanssen KF (2014)
    Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes
    J Diabetes Complications, 29 (3), 407-12
    DOI 10.1016/j.jdiacomp.2014.12.011, PubMed 25600701
  18. Svendsen M, Tonstad S, Heggen E, Pedersen TR, Seljeflot I, Bøhn SK, Bastani NE, Blomhoff R, Holme IM, Klemsdal TO (2014)
    The effect of kiwifruit consumption on blood pressure in subjects with moderately elevated blood pressure: a randomized, controlled study
    Blood Press, 24 (1), 48-54
    DOI 10.3109/08037051.2014.976979, PubMed 25483553
  19. Ulimoen SR, Enger S, Norseth J, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A (2014)
    Improved rate control reduces cardiac troponin T levels in permanent atrial fibrillation
    Clin Cardiol, 37 (7), 422-7
    DOI 10.1002/clc.22281, PubMed 24700386
  20. Wexels F, Dahl OE, Pripp AH, Seljeflot I, Borris LC, Haslund A, Gudmundsen TE, Lauritzen T, Lassen MR (2014)
    Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism
    Thromb Res, 134 (1), 68-71
    DOI 10.1016/j.thromres.2014.04.011, PubMed 24824294
  21. Wonnerth A, Katsaros KM, Krychtiuk KA, Speidl WS, Kaun C, Thaler K, Huber K, Wojta J, Maurer G, Seljeflot I, Arnesen H, Weiss TW (2014)
    Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels
    Metabolism, 63 (5), 647-53
    DOI 10.1016/j.metabol.2014.02.005, PubMed 24629561

Publications 2013

  1. Arnesen H, Seljeflot I (2013)
    The challenge of judging data on the effects of N-3 fatty acids in CHD
    Scand Cardiovasc J, 47 (2), 67-8
    DOI 10.3109/14017431.2012.761348, PubMed 23327650
  2. Berge T, Ulimoen SR, Enger S, Arnesen H, Seljeflot I, Tveit A (2013)
    Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly
    Scand J Clin Lab Invest, 73 (4), 326-33
    DOI 10.3109/00365513.2013.780093, PubMed 23586783
  3. Grundvold I, Skretteberg PT, Engeseth K, Gjesdal K, Kjeldsen SE, Arnesen H, Bodegard J, Liestøl K, Erikssen G, Erikssen J (2013)
    Response to Letter by Morris et al regarding article, "Low heart rates predict incident atrial fibrillation in healthy middle-aged men" by Grundvold et al
    Circ Arrhythm Electrophysiol, 6 (6), e102
    DOI 10.1161/CIRCEP.113.001154, PubMed 24347602
  4. Grundvold I, Skretteberg PT, Liestøl K, Erikssen G, Engeseth K, Gjesdal K, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2013)
    Low heart rates predict incident atrial fibrillation in healthy middle-aged men
    Circ Arrhythm Electrophysiol, 6 (4), 726-31
    DOI 10.1161/CIRCEP.113.000267, PubMed 23873309
  5. Hopp E, Bjørnerud A, Lunde K, Solheim S, Aakhus S, Arnesen H, Forfang K, Edvardsen T, Smith HJ (2013)
    Perfusion MRI at rest in subacute and chronic myocardial infarct
    Acta Radiol, 54 (4), 401-11
    DOI 10.1177/0284185113475605, PubMed 23401603
  6. Husebye T, Eritsland J, Müller C, Sandvik L, Arnesen H, Seljeflot I, Mangschau A, Bjørnerheim R, Andersen GØ (2013)
    Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study
    Eur J Heart Fail, 15 (5), 565-72
    DOI 10.1093/eurjhf/hfs215, PubMed 23288914
  7. Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I (2013)
    The co-existence of the IL-18+183 A/G and MMP-9 -1562 C/T polymorphisms is associated with clinical events in coronary artery disease patients
    PLoS One, 8 (9), e74498
    DOI 10.1371/journal.pone.0074498, PubMed 24040261
  8. Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Weiss T, Eritsland J, Andersen GØ (2013)
    IL-6 signalling in patients with acute ST-elevation myocardial infarction
    Results Immunol, 4, 8-13
    DOI 10.1016/j.rinim.2013.11.002, PubMed 24707455
  9. Rønning B, Wyller TB, Jordhøy MS, Nesbakken A, Bakka A, Seljeflot I, Kristjansson SR (2013)
    Frailty indicators and functional status in older patients after colorectal cancer surgery
    J Geriatr Oncol, 5 (1), 26-32
    DOI 10.1016/j.jgo.2013.08.001, PubMed 24484715
  10. Skretteberg PT, Grundvold I, Kjeldsen SE, Engeseth K, Liestøl K, Erikssen G, Erikssen J, Gjesdal K, Bodegard J (2013)
    Seven-year increase in exercise systolic blood pressure at moderate workload predicts long-term risk of coronary heart disease and mortality in healthy middle-aged men
    Hypertension, 61 (5), 1134-40
    DOI 10.1161/HYPERTENSIONAHA.111.00793, PubMed 23529164
  11. Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2013)
    Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
    Thromb J, 11 (1), 1
    DOI 10.1186/1477-9560-11-1, PubMed 23311309
  12. Tveit A, Seljeflot I, Smith P, Arnesen H, Svendsen JH (2013)
    Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation
    Immunobiology, 218 (10), 1256-60
    DOI 10.1016/j.imbio.2013.04.014, PubMed 23731775
  13. Ulimoen SR, Enger S, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A (2013)
    Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation
    Eur Heart J, 35 (8), 517-24
    DOI 10.1093/eurheartj/eht429, PubMed 24135831
  14. Vengen OA, Abdelnoor M, Westheim AS, Smith G, Fjeld NB (2013)
    Outcome of mitral valve plasty or replacement: atrial fibrillation an effect modifier
    J Cardiothorac Surg, 8, 142
    DOI 10.1186/1749-8090-8-142, PubMed 23724788
  15. Weiss TW, Arnesen H, Seljeflot I (2013)
    Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness
    Metabolism, 62 (7), 1008-13
    DOI 10.1016/j.metabol.2013.01.019, PubMed 23428306
  16. Wexels F, Haslund A, Dahl OE, Pripp AH, Gudmundsen TE, Laszlo F, Seljeflot I, Borris LC, Lassen MR (2013)
    Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verification
    Thromb Res, 131 (6), 560-3
    DOI 10.1016/j.thromres.2013.04.019, PubMed 23680105

Publications 2012

  1. Angel K, Provan SA, Mowinckel P, Seljeflot I, Kvien TK, Atar D (2012)
    The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness
    Atherosclerosis, 225 (1), 160-5
    DOI 10.1016/j.atherosclerosis.2012.08.033, PubMed 23014354
  2. Bliksøen M, Mariero LH, Ohm IK, Haugen F, Yndestad A, Solheim S, Seljeflot I, Ranheim T, Andersen GØ, Aukrust P, Valen G, Vinge LE (2012)
    Increased circulating mitochondrial DNA after myocardial infarction
    Int J Cardiol, 158 (1), 132-4
    DOI 10.1016/j.ijcard.2012.04.047, PubMed 22578950
  3. Bratseth V, Pettersen AÅ, Opstad TB, Arnesen H, Seljeflot I (2012)
    Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
    Thromb J, 10 (1), 12
    DOI 10.1186/1477-9560-10-12, PubMed 22883224
  4. Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
    The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial
    Diabetes Care, 35 (5), 1095-7
    DOI 10.2337/dc11-1895, PubMed 22446172
  5. Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
    Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095-1097
    Diabetes Care, 35 (11), E80
  6. Grundvold I, Skretteberg PT, Liestøl K, Erikssen G, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2012)
    Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study
    Hypertension, 59 (2), 198-204
    DOI 10.1161/HYPERTENSIONAHA.111.179713, PubMed 22252392
  7. Grundvold I, Skretteberg PT, Liestøl K, Gjesdal K, Erikssen G, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2012)
    Importance of physical fitness on predictive effect of body mass index and weight gain on incident atrial fibrillation in healthy middle-age men
    Am J Cardiol, 110 (3), 425-32
    DOI 10.1016/j.amjcard.2012.03.043, PubMed 22579085
  8. Halvorsen S (2012)
    STEMI treatment in areas remote from primary PCI centres
    EuroIntervention, 8 Suppl P, P44-50
    DOI 10.4244/EIJV8SPA8, PubMed 22917789
  9. Halvorsen S, Seljeflot I, Weiss T, Bøhmer E, Arnesen H (2012)
    Inflammatory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy
    Thromb Res, 130 (3), 495-500
    DOI 10.1016/j.thromres.2012.04.016, PubMed 22607887
  10. Hassellund SS, Flaa A, Kjeldsen SE, Seljeflot I, Karlsen A, Erlund I, Rostrup M (2012)
    Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study
    J Hum Hypertens, 27 (2), 100-6
    DOI 10.1038/jhh.2012.4, PubMed 22336903
  11. Karlsen A, Svendsen M, Seljeflot I, Laake P, Duttaroy AK, Drevon CA, Arnesen H, Tonstad S, Blomhoff R (2012)
    Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers
    J Hum Hypertens, 27 (2), 126-30
    DOI 10.1038/jhh.2011.116, PubMed 22258209
  12. Lindholm E, Seljeflot I, Aune E, Kirkebøen KA (2012)
    Proinflammatory cytokines and complement activation in salvaged blood from abdominal aortic aneurism surgery and total hip replacement surgery
    Transfusion, 52 (8), 1761-9
    DOI 10.1111/j.1537-2995.2011.03528.x, PubMed 22304534
  13. Njerve IU, Pettersen AÅ, Opstad TB, Arnesen H, Seljeflot I (2012)
    Fractalkine and its receptor (CX3CR1) in patients with stable coronary artery disease and diabetes mellitus
    Metab Syndr Relat Disord, 10 (6), 400-6
    DOI 10.1089/met.2012.0052, PubMed 22897138
  14. Pettersen AÅ, Arnesen H, Opstad TB, Bratseth V, Seljeflot I (2012)
    Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease
    Thromb Res, 130 (3), 424-8
    DOI 10.1016/j.thromres.2012.06.016, PubMed 22795340
  15. Pettersen AÅ, Seljeflot I, Abdelnoor M, Arnesen H (2012)
    High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)
    J Am Heart Assoc, 1 (3), e000703
    DOI 10.1161/JAHA.112.000703, PubMed 23130135
  16. Seljeflot I (2012)
    Plasma asymmetric dimethylarginine in patients with acute decompensation of chronic heart failure
    Heart, 98 (11), 831-2
    DOI 10.1136/heartjnl-2012-301932, PubMed 22581731
  17. Seljeflot I, R Ulimoen S, Enger S, Bratseth V, Arnesen H, Tveit A (2012)
    Asymmetric Dimethylarginine Levels are Highly Associated With Atrial Fibrillation in an Elderly Population
    Cardiol Res, 3 (3), 109-115
    DOI 10.4021/cr175w, PubMed 28352406
  18. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D (2012)
    ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    Eur Heart J, 33 (20), 2569-619
    DOI 10.1093/eurheartj/ehs215, PubMed 22922416
  19. Ulimoen SR, Enger S, Carlson J, Platonov PG, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A (2012)
    Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation
    Am J Cardiol, 111 (2), 225-30
    DOI 10.1016/j.amjcard.2012.09.020, PubMed 23111138

Publications 2011

  1. Andersen GØ, Knudsen EC, Aukrust P, Yndestad A, Oie E, Müller C, Seljeflot I, Ueland T (2011)
    Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
    Heart, 97 (6), 460-5
    DOI 10.1136/hrt.2010.206714, PubMed 21270073
  2. Andersen GØ, Ueland T, Knudsen EC, Scholz H, Yndestad A, Sahraoui A, Smith C, Lekva T, Otterdal K, Halvorsen B, Seljeflot I, Aukrust P (2011)
    Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation
    Diabetes, 60 (5), 1544-51
    DOI 10.2337/db10-1493, PubMed 21464440
  3. Bendz B, Endresen K, Eritsland J, Arnesen H (2011)
    [Don't withdraw all blood platelet inhibitors]
    Tidsskr Nor Laegeforen, 131 (8), 800; author reply 800
    DOI 10.4045/tidsskr.11.0278, PubMed 21556070
  4. Byrkjeland R, Nilsson BB, Westheim AS, Arnesen H, Seljeflot I (2011)
    Inflammatory markers as related to disease severity in patients with chronic heart failure: limited effects of exercise training
    Scand J Clin Lab Invest, 71 (7), 598-605
    DOI 10.3109/00365513.2011.598943, PubMed 21831004
  5. Bøhmer E, Kristiansen IS, Arnesen H, Halvorsen S (2011)
    Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction
    Eur J Cardiovasc Prev Rehabil, 18 (5), 717-23
    DOI 10.1177/1741826711398425, PubMed 21450598
  6. Grøgaard HK, Solheim S, Landsverk KS, Seljeflot I, Hoffmann P, Arnesen H, Ilebekk A (2011)
    Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris
    Scand J Clin Lab Invest, 71 (4), 322-9
    DOI 10.3109/00365513.2011.565367, PubMed 21463159
  7. Karlsen A, Svendsen M, Seljeflot I, Sommernes MA, Sexton J, Brevik A, Erlund I, Serafini M, Bastani N, Remberg SF, Borge GI, Carlsen MH, Bøhn SK, Myhrstad MC, Dragsted LO, Duttaroy AK, Haffner K, Laake P, Drevon CA, Arnesen H, Collins A, Tonstad S, Blomhoff R (2011)
    Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers
    Br J Nutr, 106 (4), 557-71
    DOI 10.1017/S0007114511000353, PubMed 21806852
  8. Kirkhus B, Lamglait A, Eilertsen KE, Falch E, Haider T, Vik H, Hoem N, Hagve TA, Basu S, Olsen E, Seljeflot I, Nyberg L, Elind E, Ulven SM (2011)
    Effects of similar intakes of marine n-3 fatty acids from enriched food products and fish oil on cardiovascular risk markers in healthy human subjects
    Br J Nutr, 107 (9), 1339-49
    DOI 10.1017/S0007114511004508, PubMed 21917191
  9. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GO (2011)
    Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
    BMC Endocr Disord, 11, 14
    DOI 10.1186/1472-6823-11-14, PubMed 21801387
  10. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2011)
    Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction
    J Thromb Haemost, 9 (8), 1468-74
    DOI 10.1111/j.1538-7836.2011.04377.x, PubMed 21624046
  11. Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I (2011)
    Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study
    Cardiovasc Diabetol, 10, 110
    DOI 10.1186/1475-2840-10-110, PubMed 22141572
  12. Opstad TB, Pettersen AA, Weiss TW, Akra S, Øvstebø R, Arnesen H, Seljeflot I (2011)
    Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease
    Clin Chim Acta, 413 (1-2), 113-20
    DOI 10.1016/j.cca.2011.09.004, PubMed 21963461
  13. Patrono C, Andreotti F, Arnesen H, Badimon L, Baigent C, Collet JP, De Caterina R, Gulba D, Huber K, Husted S, Kristensen SD, Morais J, Neumann FJ, Rasmussen LH, Siegbahn A, Steg PG, Storey RF, Van de Werf F, Verheugt F (2011)
    Antiplatelet agents for the treatment and prevention of atherothrombosis
    Eur Heart J, 32 (23), 2922-32
    DOI 10.1093/eurheartj/ehr373, PubMed 22019823
  14. Pettersen AA, Arnesen H, Opstad TB, Seljeflot I (2011)
    The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel
    Thromb J, 9, 4
    DOI 10.1186/1477-9560-9-4, PubMed 21426546
  15. Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2011)
    The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction
    Thromb Res, 130 (5), 765-8
    DOI 10.1016/j.thromres.2011.11.045, PubMed 22192151
  16. Weiss TW, Arnesen H, Trøseid M, Kaun C, Hjerkinn EM, Huber K, Wojta J, Seljeflot I (2011)
    Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose
    Wien Klin Wochenschr, 123 (21-22), 650-4
    DOI 10.1007/s00508-011-0028-6, PubMed 21842238
  17. Weiss TW, Eritsland J (2011)
    Anterior or inferior?
    Wien Klin Wochenschr, 123 (9-10), 268
    DOI 10.1007/s00508-010-1521-z, PubMed 21253773
  18. Weiss TW, Eritsland J (2011)
    ECG in acute myocardial infarction - inferior not anterior but left and right Reply
    Wien. Klin. Wochen., 123 (15-16), 520
  19. Weiss TW, Seljeflot I, Hjerkinn EM, Arnesen H (2011)
    Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease
    Int J Clin Pract, 65 (9), 939-44
    DOI 10.1111/j.1742-1241.2011.02717.x, PubMed 21849008

Publications 2010

  1. Arnesen H (2010)
    Thrombocardiology: an update
    Expert Rev Cardiovasc Ther, 8 (3), 331-3
    DOI 10.1586/erc.10.9, PubMed 20222811
  2. Arnesen H, Seljeflot I (2010)
    Studies on very long chain marine n-3 fatty acids in patients with atherosclerotic heart disease with special focus on mechanisms, dosage and formulas of supplementation
    Cell Mol Biol (Noisy-le-grand), 56 (1), 18-27
    DOI 10.1170/T875, PubMed 20196966
  3. Bøhn SK, Myhrstad MC, Thoresen M, Holden M, Karlsen A, Tunheim SH, Erlund I, Svendsen M, Seljeflot I, Moskaug JO, Duttaroy AK, Laake P, Arnesen H, Tonstad S, Collins A, Drevon CA, Blomhoff R (2010)
    Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers
    BMC Med, 8, 54
    DOI 10.1186/1741-7015-8-54, PubMed 20846424
  4. Grimsmo J, Arnesen H (2010)
    The relationship between exercise and the healthy heart: trouble in paradise?
    Expert Rev Cardiovasc Ther, 8 (8), 1047-8
    DOI 10.1586/erc.10.69, PubMed 20670180
  5. Halvorsen S, Huber K (2010)
    The role of fibrinolysis in the era of primary percutaneous coronary intervention
    Thromb Haemost, 105 (3), 390-5
    DOI 10.1160/TH10-08-0513, PubMed 21136014
  6. Kringen MK, Haug KB, Grimholt RM, Stormo C, Narum S, Opdal MS, Fosen JT, Piehler AP, Johansen PW, Seljeflot I, Berg JP, Brørs O (2010)
    Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction
    J Biomed Biotechnol, 2011, 739751
    DOI 10.1155/2011/739751, PubMed 21127708
  7. Kringen MK, Narum S, Lygren I, Seljeflot I, Sandset PM, Trøseid AM, Johansen PW, Brørs O, Holthe MR (2010)
    Reduced platelet function and role of drugs in acute gastrointestinal bleeding
    Basic Clin Pharmacol Toxicol, 108 (3), 194-201
    DOI 10.1111/j.1742-7843.2010.00643.x, PubMed 21118353
  8. Nicholls M, Halvorsen S (2010)
    Spotlight: Sigrun Halvorsen, MD, PhD, FESC
    Circulation, 121 (2), F10-F11
  9. Opstad TB, Pettersen AA, Bratseth V, Arnesen H, Seljeflot I (2010)
    The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease
    Pathophysiol Haemost Thromb, 37 (2-4), 98-103
    DOI 10.1159/000327491, PubMed 21555871
  10. Opstad TB, Pettersen AA, Weiss T, Arnesen H, Seljeflot I (2010)
    Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes
    Thromb J, 8, 7
    DOI 10.1186/1477-9560-8-7, PubMed 20444258
  11. Sandset PM, Arnesen H, Jacobsen AF, Wergeland H (2010)
    Prophylaxis against prosthetic mitral valve thrombosis with unfractionated heparin administered by an elastometric infusion pump
    Thromb Res, 126 (3), e232-4
    DOI 10.1016/j.thromres.2010.05.005, PubMed 20553950
  12. Seljeflot I, Nilsson BB, Westheim AS, Bratseth V, Arnesen H (2010)
    The L-arginine-asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training
    J Card Fail, 17 (2), 135-42
    DOI 10.1016/j.cardfail.2010.09.003, PubMed 21300303
  13. Solheim S, Seljeflot I, Lunde K, Bjørnerheim R, Aakhus S, Forfang K, Arnesen H (2010)
    Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy
    Am J Cardiol, 106 (9), 1197-200
    DOI 10.1016/j.amjcard.2010.06.043, PubMed 21029812
  14. Trøseid M, Seljeflot I, Arnesen H (2010)
    The role of interleukin-18 in the metabolic syndrome
    Cardiovasc Diabetol, 9, 11
    DOI 10.1186/1475-2840-9-11, PubMed 20331890
  15. Tveit A, Arnesen H, Smith P, Bratseth V, Seljeflot I (2010)
    L-arginine, asymmetric dimethylarginine and rhythm outcome after electrical cardioversion for atrial fibrillation
    Cardiology, 117 (3), 176-80
    DOI 10.1159/000321402, PubMed 21063118
  16. Weiss TW, Furenes EB, Trøseid M, Solheim S, Hjerkinn EM, Seljeflot I, Arnesen H (2010)
    Prediction of cardiovascular events by matrix metalloproteinase (MMP)-9 in elderly men
    Thromb Haemost, 103 (3), 679-81
    DOI 10.1160/TH09-05-0317, PubMed 20076844
  17. Weiss TW, Schumacher S, Kaun C, Katsaros KM, Trøseid M, Huber K, Maurer G, Wojta J (2010)
    Association between smoking and presence of mycoplasma pneumoniae in circulating leukocytes
    Swiss Med Wkly, 140, w13105
    DOI 10.4414/smw.2010.13105, PubMed 20927683

Publications 2009

  1. Furenes EB, Arnesen H, Solheim S, Grøgaard HK, Hoffmann P, Seljeflot I (2009)
    The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina
    Thromb Res, 124 (5), 560-4
    DOI 10.1016/j.thromres.2009.04.001, PubMed 19410278
  2. Halvorsen S, Risøe C (2009)
    [Symptoms and diagnosis of coronary heart disease in women]
    Tidsskr Nor Laegeforen, 129 (18), 1853-7
    DOI 10.4045/tidsskr.09.0115, PubMed 19844276
  3. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO (2009)
    Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
    Cardiovasc Diabetol, 8, 6
    DOI 10.1186/1475-2840-8-6, PubMed 19183453
  4. Trøseid M, Arnesen H, Hjerkinn EM, Seljeflot I (2009)
    Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men
    Metabolism, 58 (11), 1543-9
    DOI 10.1016/j.metabol.2009.04.031, PubMed 19595382
  5. Trøseid M, Lappegård KT, Mollnes TE, Arnesen H, Seljeflot I (2009)
    The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome
    Metab Syndr Relat Disord, 7 (6), 579-84
    DOI 10.1089/met.2009.0003, PubMed 19900154
  6. Tveit A, Bollmann A, Seljeflot I, Husser D, Stridh M, Sörnmo L, Arnesen H, Olsson SB, Smith P (2009)
    Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation
    Thromb Haemost, 101 (3), 601-3
    DOI 10.1160/TH08-07-0482, PubMed 19277431
  7. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Task Force per il Trattamento dell'Infarto Miocardico Acuto con, Sopraslivellamento del Tratto ST della Società Europea di Cardiologia, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C et al. (2009)
    [Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]
    G Ital Cardiol (Rome), 10 (7), 450-89
    PubMed 19761103
  8. Weiss TW, Stensaeth KH, Eritsland J (2009)
    Myocarditis in a juvenile patient with influenza A virus infection
    Eur Heart J, 31 (3), 277
    DOI 10.1093/eurheartj/ehp566, PubMed 20007610

Publications 2008

  1. Andersen GØ (2008)
    Treatment of acute decompensated heart failure: harmful effects of high doses of loop diuretics?
    Cardiology, 113 (1), 9-11
    DOI 10.1159/000164148, PubMed 18931491
  2. Haug KBF, Sharikabad MN, Kringen MK, Narum S, Sjaatil ST, Johansen PW, Kierulf P, Seljeflot I, Arnesen H, Brørs O (2008)
    Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
    Thromb J, 6, 7
    DOI 10.1186/1477-9560-6-7, PubMed 18559094
  3. Lunde K, Solheim S, Forfang K, Arnesen H, Brinch L, Bjørnerheim R, Ragnarsson A, Egeland T, Endresen K, Ilebekk A, Mangschau A, Aakhus S (2008)
    Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up
    J Am Coll Cardiol, 51 (6), 674-6
    DOI 10.1016/j.jacc.2007.10.032, PubMed 18261689
  4. Tveit A, Grundvold I, Olufsen M, Seljeflot I, Abdelnoor M, Arnesen H, Smith P (2008)
    Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial
    Int. J. Cardiol., 127 (2), 278-279
 
Page visits: 5962